Ashok Kumar Pandurangan

Ashok Kumar Pandurangan

Ashok Kumar Pandurangan is an associate professor in School of Life Sciences, B.S. Abdur Rahman Crescent Institute of Science and Technology, Vandalur, Chennai, India. He pursued his PhD in the prestigious University of Madras, Guindy campus, Chennai, India in the area of natural products as a therapeutic agent for colorectal cancer. Later, he was postdoctoral researcher in Center for Cancer research, Children's Hospital Oakland Research Institute, Oakland, California, USA. Further he completed two postdoctoral research programs in Department of Nutrition and Dietetics, Universiti of Putra Malaysia and Department of Pharmacology, University of Malaya, Malaysia. He is currently interested to work in the area of colitis associated cancer (CAC) in murine model. Colitis associated cancer is very common nowadays in developing countries. Ulcerative Colitis (UC) is a type of Inflammatory Bowel Disease (IBD), if untreated can be a risk of developing as colitis associated cancer. Numerous studies are underway to identify drugs that control both inflammation and cell proliferation. So, he is interested in identify some novel drugs from natural source and elucidate the molecular mechanisms involved in the process of curing colitis associated cancer. He published several articles on the effects of natural agents in these areas of interest.

Publications

Pharmacological Benefits of Natural Agents
Narayanaswamy Radhakrishnan, Srinivasan Vasantha, Ashok Kumar Pandurangan. © 2023. 440 pages.
Many natural products are known to have health-promoting pharmaceutical activities. For example, capsaicin, curcumin, epigallocatechin, resveratrol, and quercetin have been...
Protective Effects of Cannabis in Neuroinflammation-Mediated Alzheimer's Disease
Mohd Kashif, Mohammad Waseem, Poornima D. Vijendra, Ashok Kumar Pandurangan. © 2023. 28 pages.
In recent years, Alzheimer's disease (AD) has been recognized as an age-related neurological disorder wherein neurons degenerate and exhibit abnormal structure and function....
Role of Cannabinoids in the Regulation of Amyotrophic Lateral Sclerosis (ALS)
Akila Muthuramalingam, Ashok Kumar Pandurangan, Subhamoy Banerjee. © 2023. 17 pages.
Amyotrophic lateral sclerosis (ALS) is a degenerative disease that manifests in older adults as a result of death of motor neurons. Incidence is 60-80% sporadic and 10-20%...
Natural Products as Cancer Therapeutics
Narayanaswamy Radhakrishnan, Srinivasan Vasantha, Ashok Kumar Pandurangan. © 2023. 388 pages.
The field of cancer therapeutics faces challenges like limited treatment options, adverse side effects, and drug resistance, leaving a critical gap in addressing this disease....
Handbook of Research on Natural Products and Their Bioactive Compounds as Cancer Therapeutics
Ashok Kumar Pandurangan, Suresh Kumar Anandasadagopan, Fahad A. Alhumaydhi. © 2022. 643 pages.
Many chemotherapeutic agents are available in today’s market that are highly effective against a variety of cancer types; however, the major drawbacks of these chemotherapeutic...
An Update on the Effect of Natural Products on Oncogenic Transcription Factors in Triple Negative Breast Cancer
Ashwathi Vijayalekha, Prathibha Sivaprakasam, Suresh Kumar Anandasadagopan, Ashok Kumar Kumar Pandurangan, Tamilselvi Alagumuthu. © 2022. 26 pages.
Breast cancer is the most aggressive and rapidly growing cancer worldwide. It is classified into several subtypes among which triple negative breast cancer (TNBC) is the most...
The Molecular Mechanisms Involved in Suppressing Triple Negative Breast Cancer Using Natural Agents
Saabira Banu Sahubar Sadik, Prathibha Sivaprakasam, Nishanthi Ramasami, Ashok Kumar Pandurangan. © 2022. 27 pages.
Breast cancer is an aggressive and primary cause of death among women globally. Triple negative breast cancer (TNBC) is one of the sub types of breast cancer. TNBC lacks the...
Effects of Nigella sativa and Its Active Ingredient Thymoquinone on Breast Cancer
Syed Faisal Jahir Hussain, Mohammed Adil A., Durga Munireddy, Ashok Kumar Kumar Pandurangan. © 2022. 15 pages.
Breast cancer (BC) is the most prevalent malignancy in women. The main treatment for BC is surgery and chemotherapy. Generally, the chemotherapeutic drugs used for treatment...
Current Update on Natural Agents Against Triple Negative Breast Cancer
Prathibha Sivaprakasam, Sureshkumar Anandasadagopan, Tamilselvi Alagumuthu, Ashok Kumar Pandurangan. © 2022. 18 pages.
Breast cancer (BC) is sub-categorized into several well-recognized subtypes including estrogen receptor (ER), progesterone receptor (PR), and HER2 triple-negative breast cancer...
Diagnostic and Treatment Methods for Ulcerative Colitis and Colitis-Associated Cancer
Ashok Kumar Pandurangan. © 2021. 309 pages.
In recent years, epidemiological studies have shown a significant increase of incidences regarding ulcerative colitis (UC) in most regions of the world. At present, a common...
Protagonist of Immuno-Profiling, Immuno-Scoring, and Immunotherapy Towards Colitis-Associated Cancer: Systematic Review
Mohamed Adil, Anandraj K. Vaithy.k, Ashok Kumar Pandurangan, Mohammad Waseem, Neesar Ahmed. © 2021. 14 pages.
Chronic inflammation in the large intestinal epithelial to rectum is a major risk for malignancies. The pathogenesis of colitis associated cancer is distinct with perilous...
Diagnostic and Treatment Methods for Ulcerative Colitis and Colitis-Associated Cancer: Natural Agents Therapy for Ulcerative Colitis – Elucidating the Mechanism of Action
Syed Nasar Rahaman, Prathiba Sivaprakasam, Ashok Kumar Pandurangan, Suresh Kumar Anandasadagopan. © 2021. 29 pages.
Ulcerative colitis (UC) is a serious health problem around the world. Inflammatory bowel disease (IBD) is comprised of both Crohn's disease (CD) and UC. IBD is a clinical...
The Multifaceted Role of Natural Agents in Colitis-Associated Cancer Prevention and Therapy
Ashok Kumar Kumar Pandurangan, Suresh Kumar Anandasadagopan, Neesar Ahmed. © 2021. 20 pages.
Inflammatory bowel disease (IBD) is comprised of ulcerative colitis (UC) and Crohn's disease (CD) that was recognized by the inflammation in the colon. There are no proper...
Current Update on Natural Agents Against Triple Negative Breast Cancer
Prathibha Sivaprakasam, Sureshkumar Anandasadagopan, Tamilselvi Alagumuthu, Ashok Kumar Pandurangan. © 2020. 23 pages.
Breast cancer (BC) is sub-categorized into several well-recognized subtypes including estrogen receptor (ER), progesterone receptor (PR), and HER2 triple-negative breast cancer...